146 related articles for article (PubMed ID: 9475262)
1. Infusions with molsidomine and isosorbide-5-mononitrate in congestive heart failure: mechanisms underlying attenuation of effects.
Lehmann G; Hähnel I; Reiniger G; Lampen M; Beyerle A; Schömig A
J Cardiovasc Pharmacol; 1998 Feb; 31(2):212-20. PubMed ID: 9475262
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the hemodynamic responses to molsidomine and isosorbide dinitrate in congestive heart failure.
Unger P; Vachiery JL; de Cannière D; Staroukine M; Berkenboom G
Am Heart J; 1994 Sep; 128(3):557-63. PubMed ID: 8074020
[TBL] [Abstract][Full Text] [Related]
3. Clinical comparison of antiischemic efficacy of isosorbide dinitrate and molsidomine.
Lehmann G; Reiniger G; Beyerle A; Schömig A
J Cardiovasc Pharmacol; 1998 Jan; 31(1):25-30. PubMed ID: 9456273
[TBL] [Abstract][Full Text] [Related]
4. Hemodynamic and metabolic effects of vasodilator therapy for heart failure in acute myocardial infarction.
Kodama K; Koretsune Y; Nanto S; Taniura K
Jpn Circ J; 1984 Apr; 48(4):380-7. PubMed ID: 6425527
[TBL] [Abstract][Full Text] [Related]
5. Hemodynamic and humoral effects at rest and after head-up tilt tests during 24-hour infusion of a new nitrate ester, ITF 296, compared with ISDN and placebo in healthy volunteers: a double-blind, randomized, within-subject study.
Sardina M; Warrington SJ; Boyce M; Johnston A; Bianchini C
J Cardiovasc Pharmacol; 1995; 26 Suppl 4():S80-90. PubMed ID: 8839231
[TBL] [Abstract][Full Text] [Related]
6. Haemodynamic evaluation of two regimens of molsidomine in patients with chronic congestive heart failure.
Lehmann G; Reiniger G; Beyerle A; Zeitler H; Rudolph W
Eur J Clin Pharmacol; 1995; 48(2):109-14. PubMed ID: 7589023
[TBL] [Abstract][Full Text] [Related]
7. Haemodynamic interactions between the novel calcium sensitiser levosimendan and isosorbide-5-mononitrate in healthy subjects.
Sundberg S; Lehtonen L
Eur J Clin Pharmacol; 2000; 55(11-12):793-9. PubMed ID: 10805056
[TBL] [Abstract][Full Text] [Related]
8. Hemodynamic assessment of oral peripheral vasodilator therapy in chronic congestive heart failure: prolonged effectiveness of isosorbide dinitrate.
Williams DO; Bommer WJ; Miller RR; Amsterdam EA; Mason DT
Am J Cardiol; 1977 Jan; 39(1):84-90. PubMed ID: 318795
[TBL] [Abstract][Full Text] [Related]
9. The influence of molsidomine on the hemodynamics of patients with chronic heart failure at rest and during exercise.
Larbig DT; Milstrey HR; Nasse H; Kahle T
Am Heart J; 1985 Mar; 109(3 Pt 2):688-90. PubMed ID: 3883738
[TBL] [Abstract][Full Text] [Related]
10. Hemodynamic, anti-ischemic, and neurohumoral effects of slow-release isosorbide-5-mononitrate in patients with coronary artery disease after short- and long-term therapy.
Mitrovic V; Gessner C; Hain P; Müller KD; Schlepper M
Clin Cardiol; 1991 Mar; 14(3):209-18. PubMed ID: 1672843
[TBL] [Abstract][Full Text] [Related]
11. Hemodynamic effects of captopril and isosorbide mononitrate started early in acute myocardial infarction: a randomized placebo-controlled study.
Pipilis A; Flather M; Collins R; Coats A; Conway M; Appleby P; Sleight P
J Am Coll Cardiol; 1993 Jul; 22(1):73-9. PubMed ID: 8509566
[TBL] [Abstract][Full Text] [Related]
12. Effect of isosorbide dinitrate on response to submaximal and maximal exercise in patients with congestive heart failure.
Franciosa JA; Cohn JN
Am J Cardiol; 1979 May; 43(5):1009-14. PubMed ID: 433762
[TBL] [Abstract][Full Text] [Related]
13. Improvement of hypertension and LVH in maintenance hemodialysis patients treated with sustained-release isosorbide mononitrate.
Li H; Wang SX
J Nephrol; 2011; 24(2):236-45. PubMed ID: 21240870
[TBL] [Abstract][Full Text] [Related]
14. [Acute hemodynamic effects of SIN-1 and isosorbide dinitrate in stable left ventricular failure: a comparative double-blind, cross-over study].
Himbert D; Spreux-Varoquaux O; Jaeger P; Himbert C; Cohen-Solal A; Advenier C; Gourgon R
Ann Cardiol Angeiol (Paris); 1992 Oct; 41(8):455-62. PubMed ID: 1298186
[TBL] [Abstract][Full Text] [Related]
15. Hemodynamic effects of molsidomine, isosorbide dinitrate, and nifedipine at rest and during exercise.
Schartl M; Dougherty C; Rutsch W; Schmutzler H
Am Heart J; 1985 Mar; 109(3 Pt 2):649-53. PubMed ID: 3838401
[TBL] [Abstract][Full Text] [Related]
16. Prevention of tolerance to hemodynamic effects of nitrates with concomitant use of hydralazine in patients with chronic heart failure.
Gogia H; Mehra A; Parikh S; Raman M; Ajit-Uppal J; Johnson JV; Elkayam U
J Am Coll Cardiol; 1995 Dec; 26(7):1575-80. PubMed ID: 7594088
[TBL] [Abstract][Full Text] [Related]
17. Improved exercise capacity and differing arterial and venous tolerance during chronic isosorbide dinitrate therapy for congestive heart failure.
Leier CV; Huss P; Magorien RD; Unverferth DV
Circulation; 1983 Apr; 67(4):817-22. PubMed ID: 6337742
[TBL] [Abstract][Full Text] [Related]
18. Echo-dipyridamole stress test evaluation of isosorbide-5-mononitrate efficacy and tolerance in patients with coronary heart disease: interplay with sympathetic activity.
Longobardi G; Ferrara N; Leosco D; Abete P; Iannuzzi GL; Acanfora D; Furgi G; Nicolino A; Pinna G; Rengo F
J Cardiovasc Pharmacol; 2000 Jul; 36(1):50-5. PubMed ID: 10892660
[TBL] [Abstract][Full Text] [Related]
19. [Nitrates in the treatment of heart failure].
Dirschinger J; Hall D; Rudolph W
Herz; 1990 Jun; 15(3):171-8. PubMed ID: 2115855
[TBL] [Abstract][Full Text] [Related]
20. Differences in the antiischaemic effects of molsidomine and isosorbide dinitrate (ISDN) during acute and short-term administration in stable angina pectoris.
Wagner F; Gohlke-Bärwolf C; Trenk D; Jähnchen E; Roskamm H
Eur Heart J; 1991 Sep; 12(9):994-9. PubMed ID: 1936012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
